Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 282 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/03
End: 03/31/06
Due: 03/31/07
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 01/02/18
End: 03/05/18
Due: 03/05/19
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: -
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 02/01/09
End: 08/16/17
Due: 08/16/18
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 08/31/04
End: 11/30/04
Due: 11/30/05
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 07/11/11
End: 12/19/17
Due: 12/19/18
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 01/01/08
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 11/30/04
Due: 11/30/05
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 02/14/19
End: 01/08/20
Due: 01/08/21
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 10/31/08
Due: 10/31/09